Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -9.39%3.73B | -7.18%2.5B | -6.09%1.15B | -20.76%5.89B | -27.94%4.12B | -34.49%2.69B | -35.48%1.22B | -22.75%7.43B | -19.35%5.72B | -17.02%4.11B |
| Operating income | -9.39%3.73B | -7.18%2.5B | -6.09%1.15B | -20.76%5.89B | -27.94%4.12B | -34.49%2.69B | -35.48%1.22B | -22.75%7.43B | -19.35%5.72B | -17.02%4.11B |
| Cost of sales | 18.64%-3.17B | 18.44%-2.09B | 17.82%-1.01B | 16.73%-5.29B | 20.05%-3.89B | 26.10%-2.56B | 28.97%-1.22B | 23.65%-6.36B | 19.65%-4.87B | 17.12%-3.46B |
| Operating expenses | 18.64%-3.17B | 18.44%-2.09B | 17.82%-1.01B | 16.73%-5.29B | 20.05%-3.89B | 26.10%-2.56B | 28.97%-1.22B | 23.65%-6.36B | 19.65%-4.87B | 17.12%-3.46B |
| Gross profit | 150.76%563.93M | 209.25%411.24M | 62,174.89%143.39M | -44.64%592.56M | -73.41%224.89M | -79.42%132.98M | -100.13%-231K | -16.96%1.07B | -17.56%845.75M | -16.48%646.01M |
| Selling expenses | -4.66%-258.67M | 0.81%-161.84M | 2.82%-74.77M | 21.98%-348.97M | 25.75%-247.16M | 26.83%-163.17M | 17.97%-76.94M | -2.29%-447.26M | -5.18%-332.85M | -8.27%-223.01M |
| Administrative expenses | 6.17%-212.68M | 3.68%-143.79M | 3.45%-75.31M | 10.57%-302.08M | 10.69%-226.67M | 10.06%-149.27M | 6.04%-78.01M | -5.89%-337.78M | -8.64%-253.81M | -7.90%-165.97M |
| Impairment and provision | 108.95%6.85M | 57.83%-23.59M | -172.17%-14.36M | -83.03%11.34M | -287.15%-76.57M | -177.15%-55.92M | ---5.28M | 119.70%66.84M | --40.91M | --72.49M |
| -Other impairment is provision | 108.95%6.85M | 57.83%-23.59M | -172.17%-14.36M | -83.03%11.34M | -287.15%-76.57M | -177.15%-55.92M | ---5.28M | 119.70%66.84M | --40.91M | --72.49M |
| Special items of operating profit | 46.76%152.2M | 124.49%110.78M | -48.98%41.53M | -4.76%211.71M | -26.47%103.7M | -53.06%49.35M | -19.43%81.39M | 23.05%222.3M | -0.49%141.03M | 22.44%105.14M |
| Operating profit | 213.45%251.63M | 203.64%192.81M | 125.89%20.47M | -71.35%164.57M | -150.29%-221.81M | -142.80%-186.03M | -180.87%-79.07M | -22.77%574.39M | -28.57%441.04M | -13.00%434.65M |
| Financing cost | 28.68%-30.46M | 43.16%-18.16M | 43.12%-9.08M | 29.88%-54.73M | 22.70%-42.71M | 11.35%-31.95M | 7.78%-15.97M | -36.77%-78.06M | -75.26%-55.26M | -165.73%-36.05M |
| Share of profits of associates | 0.71%-3.36M | -23.67%-2.23M | 24.32%-1.06M | -130.24%-50.97M | 26.22%-3.38M | 33.48%-1.8M | 9.23%-1.41M | -390.17%-22.14M | -774.05%-4.58M | -140.64%-2.71M |
| Share of profit from joint venture company | 20.00%-4.29M | 35.05%-2.5M | -5.00%-1.68M | -72.68%-4.43M | -214.50%-5.36M | -319.61%-3.85M | -143.53%-1.6M | -137.67%-2.57M | -138.79%-1.7M | -138.44%-918K |
| Earning before tax | 178.14%213.52M | 175.98%169.92M | 108.82%8.65M | -88.46%54.44M | -172.00%-273.25M | -156.62%-223.64M | -225.29%-98.05M | -31.55%471.63M | -35.66%379.5M | -18.94%394.98M |
| Tax | 66.60%-63.75M | 71.77%-52.94M | 86.12%-4.69M | 12.04%-317M | 25.99%-190.86M | 3.65%-187.56M | 8.30%-33.77M | -35.99%-360.4M | -24.55%-257.87M | -17.90%-194.66M |
| After-tax profit from continuing operations | 132.27%149.77M | 128.45%116.97M | 103.00%3.96M | -336.05%-262.57M | -481.56%-464.11M | -305.28%-411.21M | -418.18%-131.82M | -73.76%111.24M | -68.22%121.64M | -37.82%200.32M |
| Earning after tax | 132.27%149.77M | 128.45%116.97M | 103.00%3.96M | -336.05%-262.57M | -481.56%-464.11M | -305.28%-411.21M | -418.18%-131.82M | -73.76%111.24M | -68.22%121.64M | -37.82%200.32M |
| Minority profit | 168.50%3.5M | 140.21%2.55M | 142.46%878K | -78.30%1.12M | -193.40%-5.11M | -240.13%-6.35M | -370.33%-2.07M | 31.30%5.15M | -52.10%5.47M | -55.92%4.53M |
| Profit attributable to shareholders | 131.87%146.27M | 128.26%114.42M | 102.37%3.08M | -348.55%-263.68M | -495.13%-459M | -306.79%-404.85M | -419.08%-129.75M | -74.75%106.09M | -68.72%116.16M | -37.23%195.78M |
| Basic earnings per share | 131.74%0.093 | 128.29%0.073 | 102.41%0.002 | -347.06%-0.168 | -495.95%-0.293 | -306.40%-0.258 | -419.23%-0.083 | -74.63%0.068 | -68.78%0.074 | -37.19%0.125 |
| Diluted earnings per share | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.